Hélène Lasolle - Concepedia

Author

Hélène Lasolle

Hospices Civils de Lyon ORCID

Also Known As

H Lasolle, H. Lasolle, Helene Lasolle, Hélene Lasolle, Hélène Lasolle, Lasolle H, Lasolle Hélène, Lasolle, Hélène

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Hospices Civils de Lyon Université Claude Bernard Lyon 1 Inserm Centre National de la Recherche Scientifique Centre de Recherche en Cancérologie de Lyon

About

Hélène Lasolle is an author at Hospices Civils de Lyon specializing in medicine, radiation oncology, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	86
2	Health Sciences	2	2	37
3	Diabetes	1	1	14
4	Pathology	1	1	12
5	Pharmacology	1	1	23

Hélène Lasolle

Publications

948

Citations

H-Index

Page 1

	Year	Citations
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016 Ann McCormack, Olaf M. Dekkers, Stephan Petersenn, European Journal of Endocrinology	2018	269
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas Hélène Lasolle, Christine Cortet, Frédéric Castinetti, European Journal of Endocrinology	2017	135
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients Pia Burman, Jacqueline Trouillas, Marco Losa, European Journal of Endocrinology	2022	94
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study Massimo Terzolo, Paola Perotti, Rossella Libé, The Lancet Diabetes & Endocrinology	2023	67
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France Alexandre Dormoy, Magalie Haissaguerre, Géraldine Vitellius, The Journal of Clinical Endocrinology & Metabolism	2022	58
SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors Solène Castellnou, Alexandre Vasiljevic, V. Lapras, Endocrine Connections	2020	46
Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis Hélène Lasolle, Mad‐Hélénie Elsensohn, Anne Wierinckx, Acta Neuropathologica Communications	2020	41
Age- and Sex-Specific TSH Upper-Limit Reference Intervals in the General French Population: There Is a Need to Adjust Our Actual Practices Véronique Raverot, Maxime Bonjour, Juliette Abeillon du Payrat, Journal of Clinical Medicine	2020	39
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer Françoise Borson‐Chazot, Emmanuelle Dantony, F. Illouz, Thyroid	2018	32
Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study Hélène Lasolle, Amandine Ferrière, Alexandre Vasiljevic, Endocrine Connections	2019	32

Page 1